Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze EVR stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate EVR investment potential.

What is EVR stock price today?

Get real-time EVR stock price, historical data, and price charts on Financhill. Track EVR performance with our advanced analysis tools.

Is EVR a good investment?

Evaluate EVR investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy EVR stock?

To buy EVR stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of EVR?

View detailed market capitalization data and company valuation metrics for EVR on our comprehensive analysis page.

What is the P/E ratio of EVR?

Use our fundamental analysis tools to view EVR P/E ratio and compare valuation metrics with industry peers.

What are EVR earnings?

View EVR earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Evercore, Inc. 10K Form

Buy

EVR
Evercore, Inc.

Last Price:

$328.17

Seasonality Move:

5.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08	10Q	EVR/Evercore, Inc. Quarterly
2023-11-02	10Q	EVR/Evercore, Inc. Quarterly
2023-08-03	10Q	EVR/Evercore, Inc. Quarterly
2023-05-05	10Q	EVR/Evercore, Inc. Quarterly
2022-11-03	10Q	EVR/Evercore, Inc. Quarterly
2022-08-03	10Q	EVR/Evercore, Inc. Quarterly

Receive EVR News And Ratings

See the #1 stock for the next 7 days that we like better than EVR

EVR Financial Statistics

Sales & Book Value

Annual Sales:	$3B
Cash Flow:	$535.9M
Price / Cash Flow:	13.34
Annual Sales:	$46.93
Price / Book:	7.02

Profitability

EPS (TTM):	12.53850
Net Income (TTM):	$573M
Gross Margin:	$3B
Return on Equity:	30.23%
Return on Assets:	14.88%

Evercore, Inc. Earnings Forecast

Key Evercore, Inc. Financial Ratios

The Gross Profit Margin over the past 20 years for EVR is 98.64%.
The Selling, General & Administrative Expenses for EVR have been equal to 0.00% of Gross Profit Margin.
The Interest Expense is 4.01% of Operating Income.
The Net Earning history of EVR is 13.94% of Total Revenues.
Per Share Earnings over the last 22 years have been positive in 14 years.

Evercore, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Capital Markets
Sector:	Financials
Current Symbol:	EVR
CUSIP:	29977A
Website:	evercore.com

Debt

Debt-to-Equity Ratio:	0.63
Current Ratio:	2.71
Quick Ratio:	2.09

Price-to-Earnings

Trailing P/E Ratio:	36.14
Forward P/E Ratio:	18.62

EVR Technical Analysis vs Fundamental Analysis

Buy

Evercore, Inc. (EVR) is a Buy

Is Evercore, Inc. a Buy or a Sell?

Evercore, Inc. stock is rated a Buy

The current Evercore, Inc. [EVR] share price is $328.30. The Score for EVR is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.